WASHINGTON - The government approved a novel anti-AIDS pill on Friday, offering a new option for hard-to-treat patients. Manufacturer Merck & Co. said Isentress should be on pharmacy shelves within two weeks. The AIDS virus uses three different enzymes to reproduce and infect cells. Numerous drugs are available that target two of those enzymes, called protease and reverse transcriptase. Isentress is the first in a new class of medicines that blocks the third enzyme, called integrase. Added to "cocktails" of other HIV medicines, the drug can lower the amount of HIV in the blood and help infection-fighting immune cells rebound.
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment